Advanced Flower Capital (AFCG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Apr, 2026Executive summary
Completed conversion from REIT to BDC on January 1, 2026, expanding investment flexibility and sector reach.
Focused on reducing exposure to underperforming credits, disciplined portfolio management, and active redeployment into high-quality, cash-flowing businesses.
Originated $53 million in new commitments in 2025 and closed $89.7 million in new commitments post year-end.
Leadership team brings extensive experience in private credit, real estate, and public company management, supporting robust credit discipline.
2025 dividends characterized as return of capital, making distributions tax-free for shareholders.
Financial highlights
FY 2025 net interest income: $24.6 million; interest income: $31.3 million; distributable earnings: $8.7 million ($0.39/share); GAAP net loss: $20.7 million (-$0.95/share); Q4 2025 net income: $0.9 million ($0.04/share).
Portfolio principal outstanding: $317.4 million across 15 loans at year-end; $366 million as of February 25, 2026; $383 million in current commitments.
Book value per share at year-end: $7.46; total assets: $275.6 million; shareholder equity: $175.6 million.
Repurchased $13 million of unsecured bonds in Q4; $77 million remain outstanding, maturing May 2027; senior notes payable at year-end: $76.3 million; line of credit payable: $21 million.
Common stock outstanding increased to 23,528,844 shares at December 31, 2025.
Outlook and guidance
Board declared Q1 2026 dividend of $0.05/share, payable April 15, 2026.
Active pipeline increased to over $1.4 billion, driven by BDC conversion and expanded investment universe.
Focus remains on redeploying capital from non-accrual and legacy loans into performing credits to unlock future earnings.
As a BDC, aims to diversify portfolio across industries and loan types, increasing selectivity and reducing risk.
High bar for new cannabis loans due to regulatory and industry challenges; focus shifting to lower middle market non-cannabis opportunities.
Latest events from Advanced Flower Capital
- Q1 2026 net investment income was $4.8M, NAV per share rose to $7.90, and a $5M buyback was authorized.AFCG
Q1 20267 May 2026 - Cannabis lending platform delivers 20% yields and strong dividends amid rapid industry growth.AFCG
Investor presentation24 Apr 2026 - Board recommends director elections and auditor ratification, with strong governance and oversight.AFCG
Proxy filing17 Apr 2026 - Vote on director elections and auditor ratification at the May 2026 annual meeting.AFCG
Proxy filing17 Apr 2026 - Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 202510 Mar 2026 - Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCG
Q2 20242 Feb 2026 - Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCG
Q3 202414 Jan 2026 - Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCG
Q4 202424 Dec 2025 - REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCG
Registration Filing16 Dec 2025